1.
Chovatiya R, Wollenberg A, Ribero S, Saeki H, Øland C, Steffensen L, Tindberg A-M, Thyssen J, Blauvelt A. Improvement of the Head and Neck Regions with Continuous Tralokinumab treatment for Up to 4 years in Adults with Moderate-to-Severe Atopic Dermatitis. J of Skin [Internet]. 2024 Jan. 16 [cited 2024 Jul. 3];8(1):s316. Available from: https://jofskin.org/33014/index.php/skin/article/view/2394